ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Patricia A. Thistlethwaite
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thistlethwaite, P. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Thistlethwaite, P. A.
Related Collections
Right arrowRelated Article

Ann Thorac Surg 2002;73:761
© 2002 The Society of Thoracic Surgeons

Invited commentary

Patricia A. Thistlethwaite, MD, PhDa

a Division of Cardiothoracic Surgery, University of California, San Diego, 200 West Arbor Dr, San Diego, CA 92103-8892, USA

e-mail: pthistlethwaite{at}ucsd.edu

This study by Dr Menzel and coworkers represents another contribution to the growing body of literature which suggests that tricuspid regurgitation secondary to thromboembolic pulmonary hypertension is relieved by pulmonary endarterectomy. In their small series of 39 patients, 33 patients experienced variable degrees of relief of tricuspid regurgitation by echocardiographic assessment after operation. The resolution of valvular dysfunction occurred in the immediate postoperative period, and none of the patients required tricuspid valve repair or replacement.

It is well known that patients with severe pulmonary hypertension develop functional tricuspid regurgitation due to annular dilatation and right ventricular volume overload [1, 2]. Pulmonary endarterectomy is one of the few procedures in cardiothoracic surgery where operation remote to any valvular structure results in resolution of severe tricuspid regurgitation. This operation usually causes dramatic reduction in pulmonary vascular resistance and right ventricular pressure. The question remains, however, why a small subset of patients undergoing this operation do not show improvement in tricuspid regurgitation and whether these patients can be identified preoperatively for risk/benefit stratification.

We have recently demonstrated in a series of over 200 patients undergoing pulmonary endarterectomy at the University of California, San Diego that one of the factors affecting the resolution of tricuspid regurgitation and hemodynamic outcome after pulmonary endarterectomy is the type and location of thromboembolic pathology in the pulmonary artery tree encountered at the time of operation [3]. Patients with intimal thickening/fibrosis and organized thrombus/fresh clot in the main or lobar pulmonary arteries showed almost complete resolution of tricuspid regurgitation, while patients with pathology limited to segmental arteries or who had a distal small vessel vasculopathic process did not show similar valvular or hemodynamic improvement. Isolated small vessel arteriolar disease (medical hyperplasia and hypertrophy) like that seen in primary pulmonary hypertension was not improved by blind pulmonary endarterectomy. This suggests that tricuspid valve outcome is determined by the degree of surgically accessible disease encountered at the time of operation.

Long-term remodeling of the right ventricle and pulmonary vascular bed after this operation and its effect on tricuspid valve function remain to be determined. Nonetheless, it is clear in the majority of patients undergoing pulmonary endarterectomy, that tricuspid valve repair/replacement is unnecessary for early restoration of valve function. The presented study underscores the intricate balance between thromboembolic pulmonary hypertension, right heart function, and tricuspid valve anatomy and gives definitive evidence that pulmonary endarterectomy corrects tricuspid valve regurgitation in this complex group of patients.

References

  1. Thistlethwaite P.A., Auger W.R., Madani M.M., Pradhan S., Kapalanski D.P., Jamieson S.W. Pulmonary thromboendarterectomy combined with other cardiac operations: indications, surgical approach, and outcome. Ann Thorac Surg 2001;72:13-19.[Abstract/Free Full Text]
  2. Fedullo P.F., Auger W.R., Kerr K.M., Rubin L.J. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001;345:1465-1472.[Free Full Text]
  3. Thistlethwaite P.A., Mo M., Madani M.M., et al. Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy. J Thorac Cardiovasc Surg 2002.

Related Article

Improvement of tricuspid regurgitation after pulmonary thromboendarterectomy
Thomas Menzel, Thorsten Kramm, Stephan Wagner, Susanne Mohr-Kahaly, Eckhard Mayer, and Juergen Meyer
Ann. Thorac. Surg. 2002 73: 756-761. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Patricia A. Thistlethwaite
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thistlethwaite, P. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Thistlethwaite, P. A.
Related Collections
Right arrowRelated Article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS